Dermata Therapeutics Files 8-K
Ticker: DRMAW · Form: 8-K · Filed: Apr 15, 2025 · CIK: 1853816
| Field | Detail |
|---|---|
| Company | Dermata Therapeutics, Inc. (DRMAW) |
| Form Type | 8-K |
| Filed Date | Apr 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure
Related Tickers: DRMA
TL;DR
DRMA filed an 8-K on 4/15/25 - check for updates.
AI Summary
Dermata Therapeutics, Inc. filed an 8-K on April 15, 2025, reporting on various events. The filing includes information related to financial statements and exhibits, as well as other events and a Regulation FD disclosure. Specific details regarding the nature of these events or any financial figures were not provided in the excerpt.
Why It Matters
This 8-K filing indicates that Dermata Therapeutics is disclosing material information to the public, which could impact investor understanding of the company's current status.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report and does not contain specific negative or positive news in the provided excerpt.
Key Players & Entities
- Dermata Therapeutics, Inc. (company) — Registrant
- April 15, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-40739 (commission_file_number) — SEC File Number
- 3525 Del Mar Heights Rd., #322, San Diego, CA 92130 (address) — Principal executive offices
FAQ
What specific events are being disclosed in this 8-K filing?
The filing indicates it covers 'Regulation FD Disclosure', 'Other Events', and 'Financial Statements and Exhibits', but the specific details of these events are not provided in the excerpt.
When was this 8-K report filed?
The report was filed on April 15, 2025.
What is Dermata Therapeutics, Inc.'s state of incorporation?
Dermata Therapeutics, Inc. is incorporated in Delaware.
What is the SEC file number for Dermata Therapeutics, Inc.?
The SEC file number is 001-40739.
Where are Dermata Therapeutics, Inc.'s principal executive offices located?
The principal executive offices are located at 3525 Del Mar Heights Rd., #322, San Diego, CA 92130.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 15, 2025 regarding Dermata Therapeutics, Inc. (DRMAW).